📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ZoBio

1.1 - Company Overview

ZoBio Logo

ZoBio

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fee-for-service research for pharma and biotech, specializing in fragment-based drug discovery from gene-to-lead, including fragment screening and validation via biophysical and biochemical assays; proprietary Target Immobilized NMR Screening (TINS); isotopic labeling in mammalian expression to produce complex protein samples; SPR and NMR assays to detect protein-fragment interactions.

Products and services

  • Fragment-Based Drug Discovery: ZoBio delivers gene-to-lead integrated programs that include fragment screening and validation using biophysical and biochemical assays to identify and confirm protein–fragment interactions in drug discovery
  • Biophysical and Biochemical Assays: ZoBio develops SPR/NMR-based assays that detect and validate protein–fragment interactions, supporting fragment screening and confirmation for pharmaceutical and biotechnology research
  • Target Immobilized NMR Screening (TINS): ZoBio engineers proprietary NMR screening to interrogate fragment libraries and confirm productive compound–protein interactions using immobilized targets for interaction verification

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ZoBio

Caliper Life Sciences Logo

Caliper Life Sciences

HQ: United States Website
  • Description: Provider of integrated systems consisting of instruments, software and reagents, laboratory automation tools, and assay and discovery services for pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caliper Life Sciences company profile →
Distributed Bio Logo

Distributed Bio

HQ: United States Website
  • Description: Provider of computational tools, antibody libraries, and an end-to-end antibody discovery and optimization platform for therapeutic programs, integrating target discovery through clinical development to address challenging targets including GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Distributed Bio company profile →
Inscripta Logo

Inscripta

HQ: United States Website
  • Description: Provider of digital genome engineering solutions for life sciences.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inscripta company profile →
Cytoo Logo

Cytoo

HQ: France Website
  • Description: Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cytoo company profile →
Lino Biotech Logo

Lino Biotech

HQ: Switzerland Website
  • Description: Provider of focal molography—an entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samples—eliminating signal disturbances due to temperature changes or non-specific binding.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lino Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ZoBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ZoBio

2.2 - Growth funds investing in similar companies to ZoBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ZoBio

4.2 - Public trading comparable groups for ZoBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ZoBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ZoBio

What does ZoBio do?

ZoBio is a provider of fee-for-service research for pharma and biotech, specializing in fragment-based drug discovery from gene-to-lead, including fragment screening and validation via biophysical and biochemical assays; proprietary Target Immobilized NMR Screening (TINS); isotopic labeling in mammalian expression to produce complex protein samples; SPR and NMR assays to detect protein-fragment interactions.

Who are ZoBio's competitors?

ZoBio's competitors and similar companies include Caliper Life Sciences, Distributed Bio, Inscripta, Cytoo, and Lino Biotech.

Where is ZoBio headquartered?

ZoBio is headquartered in The Netherlands.

How many employees does ZoBio have?

ZoBio has 1,000 employees 🔒.

When was ZoBio founded?

ZoBio was founded in 2010 🔒.

What sector and industry vertical is ZoBio in?

ZoBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ZoBio

Who are the top strategic acquirers in ZoBio's sector and industry

Top strategic M&A buyers and acquirers in ZoBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ZoBio?

Top strategic M&A buyers groups and sectors for ZoBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ZoBio's sector and industry vertical

Which are the top PE firms investing in ZoBio's sector and industry vertical?

Top PE firms investing in ZoBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ZoBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ZoBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ZoBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ZoBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ZoBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ZoBio?

The key public trading comparables and valuation benchmarks for ZoBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ZoBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ZoBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ZoBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ZoBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ZoBio's' sector and industry vertical?

Access recent funding rounds and capital raises in ZoBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ZoBio